Blog

Drew Moghanaki shared a study from Duke University on Stage I NSCLC

Photo taken from Drew Moghanaki/X

Jan 8, 2024, 14:21

Drew Moghanaki shared a study from Duke University on Stage I NSCLC

Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on X/Twitter:

“An interdisciplinary group at Duke University recently compared the time to treatment for patients with Stage I Non-Small Cell Lung Cancer, who undergo a thoracic surgery evaluation or not.

At UCLA, the thoracic surgery team is spectacular at expediting work up to minimize the time it takes to start Body Radiotherapy (SBRT). (Not a typo)”

Read further.

Source: Drew Moghanaki/X

cancer Drew Moghanaki Duke University Lung cancer non small cell lung cancer NSCLC OncoDaily Oncology SBRT Stereotactic Body Radiotherapy UCLA Health Jonsson Cancer Center

New Paper Alert! HR+ Breast Cancer: Efficacy of Subsequent Treatments After CDK4/6 Inhibitor Progression

Carlos Rodriguez-Galindo: The Man Who Will Cure the World

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

Special Coverage